Align Technology Advanced Treatment Planning Patent Affirmed by Three-Judge Panel

SAN JOSE, CA—(Marketwired – February 08, 2018) – Align Technology, Inc. (NASDAQ: ALGN) announced today that on February 5, 2018, a three–judge panel of the Patent Trial and Appeal Board (“PTAB”) entered its decision refusing to institute an inter partes review (“IPR”) trial proceeding sought by ClearCorrect to challenge the patentability of Align's patent no. 8,038,444, entitled “Automated Treatment Staging for Teeth” (“the '444 patent”). The decision found that ClearCorrect had failed to show a reasonable likelihood that any of the 42 claims in the '444 patent were unpatentable, and thus the panel unanimously refused to institute the trial proceeding requested by ClearCorrect.

The claims of the '444 patent relate to methods, systems, and devices for computer implemented treatment staging of tooth movements during an alignment treatment. The '444 patent was filed on August 30, 2007 and does not expire until 2030.

“We're pleased that the Appeal Board affirmed our advanced treatment planning patent, which is just one of many patents that make up Align's robust intellectual property portfolio and that will benefit Align through the next decade and beyond,” said Roger E. George, Align Technology vice president and general counsel. “We believe ClearCorrect initiated this action against the '444 patent because of the advanced technology it covers and the fact that it does not expire until 2030. Align will continue to vigorously defend its patents against challenges and enforce them against infringers where appropriate.”

About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align's products help dental professionals achieve the clinical results they expect and deliver effective, cutting–edge dental options to their patients. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about iTero digital scanning system, please visit www.itero.com.

Align Technology to Speak at Upcoming Financial Conferences

SAN JOSE, CA—(Marketwired – February 08, 2018) – Align Technology, Inc. (NASDAQ: ALGN) today announced that the company is scheduled to speak at upcoming financial conferences. The presentation, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately three months.

Conference: LEERINK Partners 7th Annual Global Healthcare Conference, New York, New York
Date: Thursday, February 15, 2018
Presentation: 1:30 p.m. Eastern Standard Time
Speakers: John Morici, CFO
Shirley Stacy, VP Finance, Corporate and Investor Communications

Conference: Morgan Stanley European MedTech & Services Conference, London, England
Date: Monday, February 26, 2018
Format: One–on–One Forum, No Company Presentation
Speakers: Simon Beard, VP and MD, EMEA
Yin Cantor, Director, Corporate and Investor Communications

About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align's products help dental professionals achieve the clinical results they expect and deliver effective, cutting–edge dental options to their patients. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about iTero digital scanning system, please visit www.itero.com.

Fenwick Releases IPO Report Covering Key 2017 Trends

MOUNTAIN VIEW, CA—(Marketwired – February 08, 2018) – The subdued trend in the market for tech and life sciences IPO activity continued in the second half of 2017 despite a slight increase in the number of companies completing offerings in the second half of the year. These and other findings are noted in Fenwick & West's latest IPO report released today.

The report, Key Metrics for Technology and Life Sciences Initial Public Offerings 2017, analyzed 65 technology and life sciences IPOs completed in 2017. It is authored by Fenwick partners Jeffrey Vetter and Daniel Winnike.

Of the 65 IPOs last year, 38 offerings (13 tech, 25 life sciences) were completed in H2 2017, compared to 27 (12 tech, 15 life sciences) in H1 2017. In 2016, just 51 tech and life sciences companies went public. Of those, 31 did so in the second half of the year and 20 in the first half.

“As anticipated, IPO market activity improved slightly in the second half of 2017 although technology companies accessing private sources of capital continued to delay their entry into public–company status for longer periods than in the past,” Winnike said. “The fact that all but one of the technology IPOs completed in the second half of 2017 was done in the fourth quarter suggests momentum in the market heading into 2018.”

The average offering proceeds in H2 2017 were $223.5 million for technology companies and $96.3 million for life sciences companies.

“In line with prior periods, the size of tech offerings was notably larger than their life sciences counterparts, but life sciences offerings closed at double the rate of tech in the second half,” Vetter said.

Insights for H2 2017 from the latest Fenwick IPO survey include:

Fueled by Life Sciences, IPO Activity Up Slightly in H2 2017

  • 65 technology and life sciences IPOs were completed in 2017, compared to 51 the prior year.
  • The 25 life sciences IPOs in H2 2017 represent an increase from 15 in H1 2017. This compares to an average of 23 transactions in the half–year periods beginning with 2012.
  • On the other hand, the number of technology IPOs in H2 2017 was only 13, compared to 16, the average number of technology IPOs in the half–year periods beginning with 2012.

Tech IPO Valuations Higher than Life Sciences

  • Consistent with prior periods, technology offerings were notably larger than their life sciences counterparts.
  • The average offering proceeds in H2 2017 were $223.5 million for technology companies and $96.3 million for life sciences companies. This compares to $384 million average offering proceeds for technology companies — boosted by the $3 billion Snap IPO — and $75 million for life sciences companies in H1 2017.

Tech Continues to Embrace Dual–Class Structures

  • Of the 13 technology companies completing IPOs in H2 2017, eight had adopted a dual–class structure.
  • Notably, all four of the internationally based technology companies (three in China, one in Singapore) employed a dual–class structure. Life sciences companies continued to have a traditional single–class structure.

Stable Pricing Environment for H2 2017 Offerings

  • 46% of technology deals priced above their red herring range and 39% priced within the range.
  • 80% of life sciences deals priced in or above their red herring range.
  • 2017 deals saw favorable first–day trading, with all technology offerings and 80% of the life sciences offerings closing above their IPO prices.

Insider Participation in Life Sciences

  • Consistent with a prevailing trend over the past several years, insider participation was an important feature of life sciences offerings.
  • Insiders purchased shares in the IPO, or in a concurrent private placement, in 21 of the 25 life sciences transactions completed in H2 2017.

Pricing Delays Common in H2 2017

  • A notable proportion of deals completed in H2 2017 had been filed with the SEC many months before the offering was completed.
  • Of the 38 completed offerings, 10 were for companies that made their initial confidential submission more than six months prior to the ultimate pricing.
  • Two of these 10 companies made their initial public filing more than 100 days prior to pricing.

About Fenwick & West
Fenwick & West LLP provides comprehensive legal services to ground–breaking technology and life sciences companies — at every stage of their lifecycle — and the investors that partner with them. We craft innovative, cost–effective and practical solutions on issues ranging from venture capital, public offerings, joint ventures, M&A and strategic relationships, to intellectual property, litigation and dispute resolution, taxation, antitrust, and employment and labor law. For more than four decades, Fenwick has helped some of the world's most recognized companies become and remain market leaders. For more information, visit fenwick.com.​​​​

Vivakor Announces Oil Reclamation MOU

LAS VEGAS, NV—(Marketwired – February 08, 2018) – Vivakor Inc. (OTC PINK: VIVK) announced today that it has engaged Inland Recycling, LLC (Inland) in a Memorandum of Understanding (MOU) for joint, oil reclamation services throughout the US. Inland owns and operates a permitted oil reclamation processing facility dedicated to the recovery and distillation of oil from various sources.

Vivakor will provide advanced technological oil–separation resources to the current operation. The Inland Recycling facility is located on a 20–acre site near Altair, Colorado County, Texas. The facility is strategically located within the greater Texas gulf coast industrial zone, which includes the Houston Ship Channel, Matagorda Bay and the emerging Corpus Christi complex. Inland contracts logistics services through numerous national tank carriers, local carriers, environmental service companies, and tank rental companies throughout the U.S. The materials processed at this site are Used Oil (lube oil), oil/water mixtures, diesel/heavy fuel oil/residual fuel oil mixtures, tank bottoms, oil–water mixtures, and crude oil/refinery petroleum fraction products and co–product materials that are not solid wastes.

Mr. David Polston, CEO and Founder (Inland) has pioneered and patented the conversion of E&P generated waste streams into a recycled environmentally–safe cement–stabilized road base. Polston's understanding of material handling and compliance with EPA regulations under the Code of Federal Regulations created the first codified pathway characterizing road base mix as non–hazardous oil and gas recycled product. In 2002 Polston was granted the first permit by the state of Texas to convert oil and gas non–hazardous wastes into an environmentally safe product. Inland utilizes established industry best practices as per written policies and procedures, including Spill Prevention, Control and Countermeasure (SPCC) plan, Storm Water Pollution Prevention Plan (SWP3), Material Acceptance Plan, and Safety Manuals. The Company has seven (7) patents in the US and abroad.

Vivakor Chairman and CEO Matt Nicosia said, “The relationship with Dave and Inland Recycling enables Vivakor to provide its technical expertise while expanding our revenue streams further as we process hundreds of thousands of tons of material and clean oil–waste in the US. Vivakor is committed to revenue diversification as it continues to expand its presence here in the US. As recently announced, our latest technological enhancements are effectively positioning us in support of multiple projects while driving our commitment to increasing shareholder value.”

Vivakor is an asset acquisition company that procures, develops and commercializes revenue producing assets across the globe. These holdings include intellectual properties that are proprietary and largely disruptive while centered principally in the natural resources sector.

ABOUT VIVAKOR, INC.
For more information please visit www.vivakor.com.

FORWARD–LOOKING STATEMENTS
This news release may contain forward–looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward–looking statements as a result of various factors and uncertainties, including economic slowdown affecting companies, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors may be incorporated herein by reference. Forward–looking statements may be identified but not limited by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” or “continue” and variations or similar expressions. We undertake no obligation to revise or update publicly any forward–looking statements for any reason.

Energy Storage Industry Veteran Joins Applied Minerals to Drive the Commercialization of DRAGONITE(TM) for Use in Lithium-ion Battery Applications

NEW YORK, NY—(Marketwired – February 08, 2018) – Applied Minerals, Inc. (the “Company” or “Applied Minerals”) (OTCQB: AMNL), a leading global producer of halloysite clay under the trade name DRAGONITE and advanced natural iron oxides under the trade name AMIRON™, is pleased to announce that Greg Nielson, Ph.D., a leading executive within the field of energy storage and renewable energy, has joined the Company as an advisor to further the commercialization of its emerging business as a supplier of materials for use in lithium–ion battery applications.

Dr. Nielson will utilize his extensive experience within the field of energy storage to drive the commercialization of DRAGONITE halloysite clay for use in a number of battery technologies as detailed in a previous release. Dr. Nielson's focus will include, among other things, the pursuit of commercial partnerships with one or more leading battery technology companies as well as the expansion of the Company's portfolio of battery–related IP.

“I am very excited to be working with Applied Minerals,” Dr. Nielson stated. “They are a powerful team with remarkable foresight. Their halloysite clay — a unique, naturally occurring nanomaterial — has already demonstrated significant improvements in lithium–ion battery performance in laboratory testing. They are poised to quickly become a strong player in the market for lithium–ion battery materials.”

Andre Zeitoun, President and CEO of Applied Minerals, added, “We are very excited to have Greg join us as an advisor. He will provide the Company with invaluable guidance as we commercialize our rapidly emerging business as a supplier of materials for next–generation lithium–ion batteries. There is no question that Greg's vast expertise and strong relationships within the battery, energy storage and solar industries will provide us a competitive edge in accelerating the commercialization of this exciting opportunity.”

Dr. Nielson was most recently the Chief Scientist of the Solar Technology Department of Vivint Solar, Inc. (NYSE: VSLR) (“Vivint Solar”), the second largest dedicated provider of distributed solar power to residential customers in the United States. While at Vivint Solar, Dr. Nielson took a leading role in the development and implementation of innovations of a number of products and services that accelerated the further adoption of clean, renewable energy technologies among Vivint Solar's customers.

Prior to Vivint Solar, Dr. Nielson was with Sandia National Laboratories (“Sandia”) for approximately eleven years. He joined Sandia as a prestigious Harry S. Truman Fellow and was ultimately named Principal Member of its technical staff. During his time at Sandia, Dr. Nielson oversaw a research and development program in solar power that included an annual budget of $5 million, a staff of 25 engineers and scientists, and the management of numerous industry and university partnerships. Dr. Nielson's work produced improvements in the performance of photovoltaic cells, modules and systems and reduced their manufacturing costs by taking advantage of scaling benefits by reducing photovoltaic cells to the micro– and nano–scale

Dr. Nielson holds a M.S. and a Ph.D. in Mechanical Engineering from Massachusetts Institute of Technology. During 2012, he was named one of the “Brilliant Ten” scientists and engineers in North America by Popular Science Magazine for his research into the use of micro– and nano–fabrication techniques to manufacture more efficient solar cells.

About Applied Minerals

Applied Minerals is the leading producer of halloysite clay and advanced natural iron oxide solutions from its wholly owned Dragon Mine property in Utah. Halloysite is aluminosilicate clay that forms naturally occurring nanotubes. In addition to serving the traditional halloysite markets for use in technical ceramics and catalytic applications, the Company has developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints, coatings and building materials, environmental remediation, agricultural applications and high–performance additives and fillers for plastic composites. Applied Minerals markets its halloysite products under the DRAGONITE™ trade name.

From its Dragon Mine property, the Company also produces a range of ultra–pure natural iron oxides consisting of hematite and goethite. Combining ultra–high purity and consistent quality, the inherent properties of the iron oxide from the Dragon Mine allow for a wide range of end uses in pigment and technical applications. Applied Minerals markets its comprehensive line of advanced natural iron oxide pigments under the AMIRON™ trade name. Additional information on the Company can be found at www.appliedminerals.com and www.AMIRONoxides.com.

Safe Harbor Statements
The following are safe harbor statements under the Private Securities Litigation Reform Act of 1995 for Applied Minerals, Inc. Some statements contained or implied in this news release may be considered forward–looking statements, which by their nature are uncertain. Consequently, actual results could materially differ. For more detailed information concerning how risks and uncertainties could affect the Company's revenue pipeline, please refer to Applied Minerals' most recent annual and quarterly reports filed with the SEC. The Company assumes no obligation to update any forward–looking information.

Envision Solar Announces Record Monthly Revenues in January of 2018

SAN DIEGO, CA—(Marketwired – February 08, 2018) – Envision Solar International, Inc., (OTCQB: EVSI) (“Envision Solar,” or the “Company”), the leading renewably energized EV charging, outdoor media and energy security products company, announced today unaudited revenue results for January of 2018.

In the first month of the new year the Company achieved monthly revenue of $2 million, which represents the highest monthly revenue in the Company's history. Revenue was achieved through the delivery of the Company's EV ARC™ products to government customers.

“Our products are increasingly being recognized as the best way to deploy EV charging in all but the easiest of locations,” said Envision Solar CEO, Desmond Wheatley. “Government and Enterprise customers can actually meet their infrastructure goals with our products. Record revenues and contracted backlog come as a result of that recognition. I'm looking forward to 2018 being a year of many such records and I congratulate our team on delivering.”

About Envision Solar International, Inc.

Envision Solar, www.envisionsolar.com, is a sustainable technology innovation company whose unique products include the patented EV ARC™, the patented Solar Tree® and the patent pending EV–Standard™ products, with EnvisionTrak™ patented solar tracking, SunCharge™ solar Electric Vehicle Charging, ARC™ technology energy storage, and EnvisionMedia™ solar advertising displays.

Based in San Diego the company employs combat veterans, disabled workers, minorities and other fine contributors to produce Made in America products. Envision Solar is listed on the OTC Bulletin Board under the symbol [EVSI]. For more information visit www.envisionsolar.com or call (760) 420–6569.

Forward–Looking Statements

This Press Release may contain forward–looking statements regarding future events or our expected future results that are subject to inherent risks and uncertainties. All statements in this Report other than statements of historical facts are forward–looking statements. Forward–looking statements are generally accompanied by terms or phrases such as “estimate,” “project,” “predict,” “believe,” “expect,” “anticipate,” “target,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may,” or other words and similar expressions that convey the uncertainty of future events or results. Statements contemplating or making assumptions regarding actual or potential sales, market size, and demand, prospective business contracts, customer orders, trends or operating results also constitute forward–looking statements. Our actual results may differ substantially from those indicated in forwarding looking statements because our business is subject to significant economic, competitive, regulatory, business and industry risks which are difficult to predict and many of which are beyond our control. Our operating results, financial condition, and business performance may be adversely affected by a general decline in the economy, unavailability of capital or financing for our prospective customers to purchase products and services from us, competition, changes in regulations, a decline in the demand for solar energy, a lack of profitability, a decline in our stock price, and other risks. We may not have adequate capital, financing or cash flow to sustain our business or implement our business plans. Current results and trends are not necessarily indicative of future results that we may achieve.